Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Chris Sale

Health Notes: Sale, Middleton, Odor, Ona, Graterol

By | at

Red Sox ace Chris Sale worked off a mound today for the first time in his recovery from March 2020 Tommy John surgery, Jen McCaffrey of the Athletic was among those to relay (Twitter link). There’s still no timetable for Sale’s potential return to game action, although getting on the mound obviously represents a notable step forward. At 18-13, the Red Sox are off to a strong start and could be a legitimate contender in a tough AL East. Boston’s rotation looks to be the weak point on the roster, but it’s held up fairly well so far. Sox starters have a middle-of-the-pack 4.02 ERA/4.00 SIERA over the season’s first month-plus.

Other health situations around the league:

  • This morning, the Mariners announced they’ve placed reliever Keynan Middleton on the 10-day injured list with a right biceps strain. Fellow righty Wyatt Mills was recalled in his place. Middleton, 27, has tossed 11 2/3 innings of five-run ball in the early going, striking out nine against six walks. Middleton, who underwent a Tommy John surgery in May 2018, spent the 2017-20 seasons with the division-rival Angels.
  • The Yankees placed infielder Rougned Odor on the 10-day injured list this afternoon. He’s dealing with a left knee sprain. Right-hander Albert Abreu was recalled to take his place on the active roster. Odor, acquired from the Rangers at the beginning of the regular season, hasn’t offered a whole lot offensively in the early going. He’s hitting just .164/.271/.361 over his first 70 plate appearances with New York. To his credit, Odor has massively improved upon his strikeout and walk rates from recent seasons though.
  • Padres outfielder Jorge Oña underwent arthroscopic surgery on his right elbow yesterday, Dennis Lin of the Athletic was among those to pass along (Twitter link). He’s expected to be out of action for six to eight weeks. Oña, 24, made a very brief MLB debut last season, tallying 15 plate appearances over five games. Other than that limited major league time, Oña only has 103 trips to the plate above the low minors (in Double-A in 2019), so he likely would’ve started the year at Triple-A El Paso even if he’d been healthy.
  • Dodgers reliever Brusdar Graterol, placed on the injured list last week because of forearm tightness, was known to be headed for an MRI. Fortunately, testing showed no structural damage, manager Dave Roberts told reporters (including Bill Plunkett of the Orange County Register). That’s especially welcome news since the flamethrowing Graterol underwent a Tommy John procedure back in 2016. There’s still no indication when he might return to game action.

East Notes: Braves, Smyly, Sale, Orioles, Kjerstad

By and | at

The Braves are planning to activate Drew Smyly from the injured list to start Saturday’s game against the Diamondbacks, David O’Brien of the Athletic was among those to relay (Twitter link). The left-hander was placed on the IL last week with forearm inflammation, but he’ll return after missing just one start. Smyly has allowed nine runs (seven earned) over his first eleven innings for Atlanta, but he’s struck out eleven with just a single walk to this point.

Elsewhere in Atlanta and the game’s East divisions:

  • In other Braves’ pitching news (also via O’Brien), reliever Chris Martin has started throwing as he begins his ramp-up. The right-hander hit the injured list in early April with shoulder inflammation but O’Brien says he could return by the end of Atlanta’s upcoming homestand, which runs through the 29th. Max Fried, who went on the shelf last week after straining his hamstring, seems to be further behind. He has not yet begun throwing and there’s no timetable for his return, per O’Brien. Like Martin, Mike Soroka is dealing with shoulder inflammation; the 23-year-old is expected to begin a throwing program sometime soon, but manager Brian Snitker suggested he’s still far away from any potential return to game action (via Gabe Burns of the Atlanta Journal-Constitution).
  • Red Sox ace Chris Sale is progressing in his recovery from March 2020 Tommy John surgery, Chris Cotillo of MassLive.com relays. Sale isn’t throwing off a mound yet, but manager Alex Cora said he’s “getting closer.” The left-hander will report to the team’s complex in Florida on Sunday to continue his rehab. Sale “feels great,” according to Cora, though the Red Sox still aren’t ready to offer a timetable on a potential 2021 return. Even without Sale, the Red Sox have surprisingly begun the season with an American League-best 12-6 record. Nathan Eovaldi and Eduardo Rodríguez have been the top performers in Boston’s rotation this year in Sale’s absence.
  • Orioles outfield prospect Heston Kjerstad has been medically cleared to report to the team’s alternate training site, per Jim Callis of MLB.com. Kjerstad, the No. 2 pick in last year’s draft, has been away from the club while recovering from myocarditis. The 22-year-old will need “a months-long buildup” before he’s ready for game action, Callis tweets.

Red Sox Claim John Schreiber, Place Chris Sale On 60-Day IL

By | at

The Red Sox announced this afternoon that they’ve claimed righty John Schreiber off waivers from the Tigers and placed left-hander Chris Sale on the 60-day injured list to open a 40-man roster spot. The Sale move shouldn’t come as a shock, given that he underwent Tommy John surgery on March 30 last year. It was reported last month that his rehab was expected to come near the back end of the typical 12-15 month recovery time. He’ll likely be an option for the Sox sometime early this summer.

Schreiber, 27 next month, has pitched 28 2/3 innings with Detroit over the past two seasons but has not fared well, logging a 6.28 ERA in that time. Other metrics are more bullish on the former 15th-round pick, however, thanks largely to an above-average 25.6 percent strikeout rate and a very manageable 6.2 percent walk rate. The sidearm-slinging Schreiber has a career 1.99 ERA in four minor league seasons, including a 2.28 mark in 59 1/3 innings at Triple-A.

Schreiber doesn’t throw particularly hard, as is common with sidearmers, but he’s been a thorn in the side of hitters throughout his minor league tenure — righties in particular. Right-handed opponents posted a laughable .192/.270/.311 slash against him in 2019. Beyond that, Schreiber has multiple minor league option years remaining, giving the Red Sox both depth and flexibility with their bullpen should they choose to keep him on the 40-man roster.

Red Sox Notes: Pedroia, Benintendi, Sale, Lester

By | at

“A resolution” between Dustin Pedroia and the Red Sox could come at some point this month, The Boston Globe’s Pete Abraham reports (Twitter link).  Knee injuries limited Pedroia to just nine games in 2018-19, and he didn’t play at all during the 2020 season, with Abraham adding that Pedroia isn’t intending to make one final comeback attempt.  2021 marks the final season of the eight-year, $110MM extension Pedroia signed in July 2013, and the second baseman is owed $12MM for the coming season.

There has been an expectation that Pedroia could be cut loose in one fashion or another once the Sox were in need of a 40-man roster spot, as their 40-man is currently full.  Some type of buyout rather than an outright release is probably the likelier route, since “given Dustin’s status, [the Sox will] want to do this correctly,” Abraham notes.  One of the key figures in this era of Red Sox baseball, Pedroia hit .299/.365/.439 over 6777 career plate appearances (all in a Sox uniform), with a resume that includes the 2008 AL MVP Award, four All-Star appearances, and World Series rings from Boston’s 2007 and 2013 championship seasons.

Some more from Fenway Park…

  • The Red Sox have asked at least one team for “a younger corner outfielder along with a minor-league pitcher not necessarily on the 40-man roster” as the trade return for Andrew Benintendi, WEEI.com’s Rob Bradford writes.  While Benintendi has drawn interest from several teams, the Phillies and Reds haven’t been involved in talks.  (The Rangers are also not in the mix, as Bradford originally reported last week.)  Former Red Sox president of baseball operations Dave Dombrowski is now running the Phils’ front office and the Reds have explored a Benintendi trade in the past, so there was speculation that those two clubs could be looking into acquiring Benintendi this time around.
  • Chris Sale’s return from Tommy John surgery is likely to come on the higher end of the usual 12-15 month recovery timeline, as ESPN.com’s Buster Olney writes that the Sox are “expected to be deliberate” in bringing the southpaw back to action.  Sale underwent his TJ procedure at the end of last March, putting him on track to return in late June or early July.  (Assuming the 2021 schedule goes as planned, it is easy to see a scenario where Sale doesn’t pitch until after the July 12-14 All-Star break.)  Since Sale is under contract through at least the 2024 season, the club is “apt to take a conservative approach” to ensure that Sale is fully recovered and ready for 2022 and beyond, rather than rushing him in any way this season.
  • The Red Sox hadn’t been in touch with Jon Lester as of December 9, Rob Bradford reported last month, and Bradford tweeted yesterday that there hadn’t been any new contact between the two sides prior to Lester’s new deal with the Nationals.  While Boston has been looking at a wide range of starting pitching options this offseason, it seems like a reunion with Lester was simply not on the club’s radar.

Pitching Notes: Soria, Zimmermann, Sale, Price, LeBlanc

By | at

It seems veteran hurler Joakim Soria is drawing quite a lot of interest from the American League West. MLB.com’s Jon Morosi tweets that the Angels, Astros, Athletics, and Rangers are all pursuing Soria to some degree. Of course, most teams could stand to add an experienced late-inning reliever coming off of a quality season, so it stands to reason that just about every club in a competitive division would give a look. Soria, 36, registered a strong 2.82 ERA last year in Oakland, though that’s hardly a determinative measure on its own for a reliever in a shortened season. The well-traveled hurler managed only a 9.6% swinging-strike rate, his lowest in quite some time, and suddenly shifted to being a heavy flyball pitcher (though he wasn’t punished with many home runs in the short sample).

More from the pitching market:

  • After wrapping up a greatly disappointing tenure with the Tigers, Jordan Zimmermann is taking quite a different free agent journey than his first one. It’s fair to wonder whether he’d consider retiring, but the 34-year-old tells MLB.com’s Jason Beck (Twitter link) that he’s instead preparing for another campaign. Zimmermann is sure to draw interest, but not on a guaranteed big-league pact. He has largely been ineffective since coming to Detroit five seasons back and is now also recovering from a forearm injury.
  • The Red Sox could soon get a good sense of the return timeline for star lefty Chris Sale. Per MassLive’s Chris Cotillo (via Twitter), Sale is expected to throw from a mound at some point in the next two weeks or so — if all goes as planned. It’s promising that he’s already nearing that milestone, having undergone his Tommy John procedure at the end of March of 2020. It is hard to imagine that Sale will be ready for the start of the season, but perhaps he could resume competitive pitching relatively early in the 2021 campaign.
  • Also on his way back is Sale’s former teammate David Price. He posted a video on Twitter showing that he’s hard at work preparing for the upcoming season. The Dodgers will surely be interested to see how the ball is coming out of the once-great lefty’s hand after a long respite. Price, who was acquired in a blockbuster nearly one year ago, has yet to take the ball with his new team. He opted out of the 2020 season.
  • Teams looking for a spot starter and long reliever will soon have another option to consider. Southpaw Wade LeBlanc is still plugging away despite suffering a tough elbow injury last year. Per MLB.com’s Jon Morosi (Twitter link), LeBlanc is in good enough form that he’s now preparing for a showcase. LeBlanc posted a resurgent 2018 season but has struggled more recently, so he’s sure to land a non-guaranteed deal when he does sign.

Latest On Chris Sale, Eduardo Rodriguez

By | at

Normally contenders, the Red Sox finished with one of the majors’ worst records in 2020, winning just 24 of 60 games. One obvious reason? They received zero contributions from their two best starters, left-handers Chris Sale and Eduardo Rodriguez, who missed the season with health problems.

While it would be nice for the Red Sox to get full years from both Sale and Rodriguez in 2021, that doesn’t appear likely. Regarding Sale, chief baseball officer Chaim Bloom revealed Thursday (via Jason Mastrodonato of the Boston Herald) that the ace won’t be available when next season begins.

“When he comes back, that’s upside,” Bloom said. “Because we know that’s not going to be at the beginning of the season.”

Sale underwent Tommy John surgery in March, and that typically requires a 12- to 15-month recovery period. With that in mind, it’s not surprising that Boston will miss Sale for some portion of time next year. But it’s still less than ideal for a team that signed Sale to a five-year, $145MM extension that just kicked in this past season.

The news is much better for Rodriguez, who on Thursday told MLB Network Radio, “I will be 100 percent ready for next season.” Rodriguez had a career campaign in 2019, but COVID-19 and myocarditis shelved him this year. He was just cleared to begin walking again in late September, so it’s remarkable that Rodriguez is on track to be in the Red Sox’s season-opening rotation in a few months.

Besides Rodriguez and Nathan Eovaldi, the Red Sox might not be sure who will be in their starting staff when next year commences. Their rotation stumbled to a bottom-of-the-barrel 5.34 ERA/5.50 FIP in 2020, though Tanner Houck and Nick Pivetta showed quite a bit of promise over a combined five starts and could earn spots. Otherwise, Boston may try to pick up at least one veteran in free agency to fill out the group.

[RELATED: Red Sox Offseason Outlook]

Latest On Chris Sale, Eduardo Rodriguez

By | at

SEPT. 25: The Red Sox received “really good news” regarding Rodriguez on Friday, Roenicke told Ian Browne of MLB.com and other reporters. Rodriguez has been cleared to start walking again in a couple of weeks, and the Red Sox are hopeful he’ll be able to have a normal offseason.

SEPT. 24: The Red Sox have gone all season without their two best starters, left-handers Chris Sale and Eduardo Rodriguez, because of health problems. Thanks in part to their absences, the Red Sox have gone a horrible 22-34 – the second-worst record in the American League. However, the hope is that the Red Sox will have one or both of the Sale-Rodriguez tandem back when the 2021 campaign commences.

Manager Ron Roenicke issued updates on Sale and Rodriguez on Thursday, saying (via Jen McCaffrey of The Athletic; Twitter links) that the former is coming along well in his recently started throwing program and the latter will meet with doctors in the coming days to determine next steps. Sale has been on the shelf since undergoing Tommy John surgery in March, while Rodriguez has been down with myocarditis after a bout with the coronavirus.

For Boston’s starting staff, there’s no doubting the importance of Sale or Rodriguez. Sale, a longtime ace, signed a five-year, $145MM extension before the 2019 season, and while his numbers dipped after that, he remained an above-average starter. He still has four guaranteed seasons left on that deal. Rodriguez has given the Red Sox solid production since he debuted in 2015, and with next season being his final year of arbitration eligibility, it could be a crucial campaign for him.

Without Sale and Rodriguez, the Red Sox’s rotation has struggled to the majors’ second-worst ERA and FIP in 2020. They’ve completely lacked solutions beyond Nathan Eovaldi and Martin Perez, who could return to the team next year as complements to Sale and Rodriguez if the latter two are well enough to pitch by then.

Red Sox Place Chris Sale On 60-Day Injured List

By | at

The Red Sox placed left-hander Chris Sale on the 60-day injured list, as per a team press release.  Sale underwent Tommy John surgery in March and will miss the entire 2020 season.

Sale’s IL placement was inevitable given the nature of his injury, though as Pete Abraham of the Boston Globe puts it, the “odd timing suggests [the Sox] may have a need for the 40-man spot” that now becomes available with Sale on the injured list.  Boston’s 40-man was full prior to the Sale transaction, so the club now has some flexibility with an open spot.

Jonathan Lucroy could be a possibility for that spot, as MLB.com’s Ian Browne reported earlier today that the Red Sox were working on a restructured version of the veteran catcher’s minor league deal, which is why Lucroy wasn’t on Boston’s initial 60-man player pool for training camp.  With teams expected to carry three catchers on their expanded MLB rosters, the Sox could choose to keep Lucroy and Kevin Plawecki as Christian Vazquez’s backups, which would require a purchase of Lucroy’s minors deal.

Marco Hernandez, Yairo Munoz, and Brian Johnson are some of the other notable non-roster players in the player pool, so Boston could be considering selecting one of their contracts as well.  Or, the Red Sox could be keeping a 40-man spot available should another player come available over the next few weeks.

Red Sox Notes: Sale, Pillar, Witte

By | at

Red Sox lefty Chris Sale spoke with reporters this week, acknowledging and even agreeing with some of the frustration felt by fans who suggested he could’ve had the surgery months ago (link via MassLive.com’s Chris Cotillo). However, like most players, Sale viewed surgery as an absolute last resort. “Some people call it wasting time. And hey, it is,” Sale conceded. “We wasted time because the end result is Tommy John. We could have done this six months ago. Having said that, I appreciate the process and I wouldn’t have been 100% go as I was this past time. We turned over every stone. We did every possible thing we could have to prevent this. And I’m okay with that.”

With Sale shelved, the Red Sox’ rotation is going to be a patchwork unit at best, should the season eventually be played out. He’s in the first season of a five-year, $145MM contract he inked with the Red Sox last spring — a deal for which he opted in lieu of testing free agency this past offseason. The 31-year-old southpaw will miss at least the first season of that deal and some of the second, but he’s hopeful that the surgery could allow him to “get 10 more great years” out of his elbow.

More on the Sox…

  • Outfielder Kevin Pillar chatted with Julian McWilliams of the Boston Globe about his revamped approach at the plate heading into the 2020 season. Long a pull-happy hitter, Pillar’s pull tendencies spiked to new heights in 2019, prompting him to refocus on taking the ball up the middle and hitting to all fields. The 31-year-old belted a career-high 21 homers last year — likely in part due to said spike in pull percentage and also due to the juiced ball — but he’s hopeful that more of all-fields approach will bring about a more well-rounded offensive game. Specifically, Pillar noted that going through the offseason and better “understanding how teams value players now” fueled his approach. Pillar, of course, was non-tendered by the Giants after racking up 21 homers, 37 doubles and four triples due in some part to his dismal .287 OBP. He eventually signed a one-year, $4.25MM deal with Boston late in the offseason.
  • Infielder Jantzen Witte, in camp as a non-roster invitee with the Sox, is in many ways a microcosm of the challenges that minor league players face as a whole, writes WEEI’s Rob Bradford. A career-long minor leaguer, Witte had never earned more than $12,000 in a single season. However, he reached minor league free agency this winter and was slated to see his earnings increase considerably, even if he simply spent the year in Triple-A. Witte, though, impressed in camp and caught the eye of manager Ron Roenicke, creating the outside possibility of securing a bench spot with the club and at least putting him on the radar for a midseason call-up. Now, he’s collecting a $400 weekly stipend through the end of May — a rate that checks in under his previous $12,000 salary even when prorated for a whole season — with no clue what’ll happen thereafter (financially speaking). Bradford spoke with Witte about his efforts to remain in shape, the financial uncertainty he’s facing and the woodcarving side business he’s started up while awaiting clarity. The 30-year-old Witte hit .277/.339/.394 in Triple-A last year while playing third base, second base, first base and left field.

Chris Sale Undergoes Tommy John Surgery

By | at

4:42pm: The surgery was performed today in Los Angeles by Dr. Neal ElAttrache, the Red Sox announced.

4:23pm: We’ve known for some time that Red Sox lefty Chris Sale was destined for Tommy John surgery. But the timing of the procedure was in some doubt given the urgent need for medical resources to deal with the still-growing coronavirus crisis.

Sale has indeed received a replacement ulnar collateral ligament in his left elbow, according to Alex Speier of the Boston Globe (via Twitter). Details on the procedure — timing, location, whether other work was also done — remain unavailable.

Several other pitchers have had TJ surgeries in recent weeks. But even if it’s legal (that depends upon location) and there’s a willing medical provider, it remains a legitimate question whether it’s ethical to perform such elective work given the dire need for medical resources around the world. Emma Baccilieri of SI.com just published a careful examination of the topic.

Now that we know Sale has had his elbow work done, it’s possible to set an estimated timeline for his return. There’s no question he’ll miss all of a truncated 2020 season, no matter how late it goes. But his status for 2021 will depend upon the course of his rehab. If all goes well, he’ll be moving toward competitive moundwork this time next year.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrowsFOX Sports Engage Network scroll to top